PRISM MarketView

PRISM Q & A Corner

PRISM CEO CORNER -Jason Matuszewski, BioStem Technologies

BioStem Technologies: Large and Growing Opportunity for Innovative Wound Care Products in Multiple Markets

22 February 2024

NeuroSense Reports Additional Positive Data from ALS Trial

New York, February 22, 2024 - PRISM MarketView -Neurodegenerative disease company, NeuroSense Therapeutics (Nasdaq: NRSN) has reported additional positive data from its six-month double-blind Phase 2b PARADIGM trial of PrimeC for the treatment of amyotrophic lateral scle...

22 February 2024

Veritone, Inc. Announces Strategic Restructuring to Accelerate Profitability and Streamline Operations

New York, February 22, 2024 - PRISM MarketView -Veritone, Inc. (NASDAQ: VERI), a leader in enterprise AI software and solutions, announced yesterday a series of restructuring initiatives that were set in motion in January 2024. These initiatives are designed to refine it...

22 February 2024

PRISM MarketView Consumer Products Index Top Mover: Coty

New York, February 21, 2024 - PRISM MarketView - Coty (NYSE: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, saw its stock up almost 4% after reiterating FY24 outlook of +9-11...

21 February 2024

Cybin Reports Positive Topline Results in Depression Study

New York, February 20, 2024 - PRISM MarketView - Cybin Inc. (NYSE American: CYBN) has reported its unaudited financial results for its third quarter ended December 31, 2023 and highlighted positive Phase 2 topline efficacy and safety data for CYB003, in the treatment of ...

20 February 2024

Biotech Bulletin: FDA Approval Delivers Vital Win for Pancreatic Cancer

New York, February 19, 2024 - PRISM MarketView -The FDA has approved the first new frontline treatment for metastatic pancreatic cancer in more than a decade. This week, global biopharmaceutical company, Ipsen, announced that it had received regulatory approval for Onivy...

19 February 2024

Revolutionizing Drug Development: How AI Shortens the Journey from Lab to Lives

New York, February 16, 2024 - PRISM MarketView - The journey of progressing a drug molecule from concept to commercialization is a lengthy and intricate process, typically spanning 10-15 years. This period encompasses the initial discovery phase, through to clinical tria...

16 February 2024

Greenwich LifeSciences Provides Update on Phase III Clinical Trial for Breast Cancer Immunotherapy; Shares Surge

New York, February 15, 2024 - PRISM MarketView - Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company, provided an update on its Phase III clinical trial, Flamingo-01, focusing on GLSI-100, an immunotherapy aimed at preventing breast ca...

15 February 2024

Village Farms Breaks Ground on Indoor Cannabis Production Facility in the Netherlands

New York, February 15, 2024 - PRISM MarketView - Village Farms International (Nasdaq: VFF) has begun construction on its first indoor cannabis production facility in Drachten, Netherlands. The company plans to fund the build-out of the facility from cash on hand.

15 February 2024

PRISM NextGen Tech Stocks Soundhound AI (SOUN) and Recursion Pharmaceuticals (RXRX) See Share Prices Soar From Nvidia Disclosure

New York, February 15, 2024 - PRISM MarketView - Today the megacap AI chipmaker Nvidia (NVDA) disclosed its stake in some smaller AI firms that has boosted shares for those associated with the disclosure.

15 February 2024